Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
2016ASTELLAS PHARMA : CHMP Issues Positive Opinion to Include New Data in European L..
PU
2016ASTELLAS PHARMA : Certain media coverage related to Astellas
PU
2016ASTELLAS PHARMA : Enters a New Collaborative Research Agreement with AIST to Dis..
PU
2016ASTELLAS PHARMA : Establishment and Start of Operations of Malaysia Subsidiary a..
PU
2016ASTELLAS PHARMA : and LEO Pharma Close Transaction to Transfer Global Dermatolog..
PU
2016ASTELLAS PHARMA INC : Ex-dividend day for final dividend
FA
2016ASTELLAS PHARMA : and Mitsubishi Tanabe Pharma Execute Agreement for Share of Co..
PU
2016ASTELLAS PHARMA : Pivotal Phase III Trial of enzalutamide Initiated in Metastati..
PU
2016ASTELLAS PHARMA : Positive top-line results from phase 3 study evaluating romoso..
PU
2016ASTELLAS PHARMA : Selected as a Nadeshiko Brand Component for Excellence in Prov..
PU
2016ASTELLAS PHARMA : Announces Personnel Changes (pdf 47KB)
PU
2016ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 92KB)
PU
2016ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 41KB)
PU
2016ASTELLAS PHARMA : Announces Personnel Changes and Organizational Change (pdf 47K..
PU
2016ASTELLAS PHARMA : Announces Management Structure Change (pdf 70KB)
PU
2016ASTELLAS PHARMA : Receives Approval for a Supplemental New Drug Application for ..
PU
2016ASTELLAS PHARMA : Submits New Drug Application for Linaclotide, Treatment for Ir..
PU
2016ASTELLAS PHARMA : POSITIVE TOP-LINE RESULTS FROM THE PHASE 3 STUDY OF ROMOSOZUMA..
PU
2016ASTELLAS PHARMA : FDA Accepts For Review Supplemental New Drug Application for X..
PU
2016ASTELLAS PHARMA : Announces Results of Tender Offer to Acquire All Outstanding S..
PU
2016ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 57..
PU
2016ASTELLAS PHARMA : and CLINO Announce License Agreement to Develop and Commercial..
PU
2016ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 139KB)
PU
2016ASTELLAS PHARMA : Extends Tender Offer to Acquire All Outstanding Shares of Ocat..
PU
2016ASTELLAS PHARMA : REPATHA® (EVOLOCUMAB) APPROVED AS FIRST PCSK9 INHIBITOR IN JAP..
PU
2016ASTELLAS PHARMA : Extension of agreement on Telmisartan (Micardis® family) (pdf ..
PU
2015ASTELLAS PHARMA : Extends Tender Offer to Acquire All Outstanding Shares of Ocat..
PU
2015ASTELLAS PHARMA : Presentation material for Press Conference on December 8 (pdf ..
PU
2015ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 46KB)
PU
2015ASTELLAS PHARMA : Announces Personnel Change (pdf 46KB)
PU
2015ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 60KB)
PU
2015ASTELLAS PHARMA : and Ironwood Report Positive Top-Line Data from Phase III IBS-..
PU
2015ASTELLAS PHARMA : Commences Tender Offer to Acquire All Outstanding Shares of Oc..
PU
2015ASTELLAS PHARMA : Transfers Its Global Dermatology Business to LEO Pharma (pdf 9..
PU
2015ASTELLAS PHARMA : Presentation for Astellas to Acquire Ocata Therapeutics (pdf 1..
PU
2015ASTELLAS PHARMA : to Acquire Ocata Therapeutics (pdf 44KB)
PU
2015ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 64KB)
PU
2015ASTELLAS PHARMA : Concludes Agreement with MicroBiopharm Japan on Transfer of Ki..
PU
2015ASTELLAS PHARMA : and Immunomic Therapeutics Announce Worldwide Partnership for ..
PU
2015ASTELLAS PHARMA : Submission of a Supplemental New Drug Application for ASP1585 ..
PU
2015ASTELLAS PHARMA : and Chromocell Announce License and Collaboration Agreement to..
PU
2015ASTELLAS PHARMA INC : Ex-dividend day for interim dividend
FA
2015ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index (pdf 77KB)
PU
2015ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 41KB)
PU
2015ASTELLAS PHARMA : Announces Acquisition of Own Shares
PU
2015ASTELLAS PHARMA : Establishes New Real World Informatics and Analytics Function
PU
2015ASTELLAS PHARMA : Provides Update on Phase 3 Study Evaluating Isavuconazole in P..
PU
2015ASTELLAS PHARMA : "Cell therapy using human iPSC-derived renal progenitors ameli..
PU
2015ASTELLAS PHARMA : Initiates Collaborative Research with National Institute of Ad..
PU
2015ASTELLAS PHARMA : "Cell therapy using human iPSC-derived renal progenitors ameli..
PU
2015ASTELLAS PHARMA : The Netherlands Decorates Masafumi Nogimori, Representative Di..
PU
2015ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 201KB)
PU
2015ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 63KB)
PU
2015ASTELLAS PHARMA : Results of Additional Analysis of Data from Japanese Clinical ..
PU
2015ASTELLAS PHARMA : and Anokion to Collaborate on Immune Tolerance Therapeutics - ..
PU
2015ASTELLAS PHARMA : and Anokion to Collaborate on Immune Tolerance Therapeutics - ..
BU
2015ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 63KB)
PU
2015ASTELLAS PHARMA : ANNOUNCES PRELIMINARY PHASE 1/2 SAFETY, TOLERABILITY AND EFFIC..
PU
2015ASTELLAS PHARMA : Strategic Plan 2015-2017 (pdf 392KB) (pdf 392 KB)
PU
2015ASTELLAS PHARMA : Strategic Plan 2015-2017 (pdf 392 KB)
PU
2015ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62KB)
PU
2015ASTELLAS PHARMA : Announcement of Approval of Additional Indication for the TNF-..
PU
2015ASTELLAS PHARMA : Receives Approval for a Supplemental New Drug Application for ..
PU
2015ASTELLAS PHARMA : AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED AT THE..
PU
2015ASTELLAS PHARMA : MIRABEGRON AS ADD-ON TREATMENT TO SOLIFENACIN THERAPY DEMONSTR..
PU
2015ASTELLAS PHARMA : Notice Regarding the Introduction of a Performance-linked Stoc..
PU
2015ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 24KB)
PU
2015ASTELLAS PHARMA : Announces Personnel Change (pdf 62KB)
PU
2015ASTELLAS PHARMA : Announces Consolidated Business Forecasts for Fiscal Year 2014..
PU
2015ASTELLAS PHARMA : The Results of Japanese Clinical Trials of Anti-TNF-alpha Anti..
PU
2015ASTELLAS PHARMA : Nominates Director and Audit & Supervisory Board Member (pdf 4..
PU
2015ASTELLAS PHARMA : and Potenza Therapeutics Partner to Build a Portfolio of Immun..
PU
2015ASTELLAS PHARMA : and Potenza Therapeutics Partner to Build a Portfolio of Immun..
BU
2015ASTELLAS PHARMA : MSD and Astellas sign a memorandum of understanding regarding ..
PU
2015ASTELLAS PHARMA : MD Anderson, Astellas Pharma Sign Option Agreement for Monoclo..
PU
Prev.1  2  3  4   5  6  7  8Next
Official Publications
2020Press Release 
2020Half-year results 
20201st quarter results 
2020Press Release 
2020Annual results 
2020Press Release 
Upcoming event on ASTELLAS PHARMA INC.
01/29/21Q3 2020 Earnings Call
Upcoming sector events
01/28/21LUPIN LIMITED : Q3 2021 Earnings Release
01/28/21SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Earnings Release
01/28/21DAIICHI SANKYO COMPANY, LIMITED : Q3 2020 Earnings Release
01/29/21SUN PHARMACEUTICAL INDUSTRIES LIMITED : Q3 2021 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - Other
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ